Skip to Main Content
Welcome to theĀ Scientist.comĀ Marketplace

Go to Main Navigation

Crystec Pharma

Year Established:
Bradford, West Yorkshire, GB
Company Type:
Small Business (1-10M TTM Revenue)

Crystec applies the latest modified supercritical antisolvent (mSAS) technology to improve the design and performance of medicines. We provide crystal and particle engineering solutions to the pharmaceutical and biopharmaceutical industries, contributing to human health by enabling new and more effective therapies. Crystec SCF technology can be applied to small and large drug molecules in a range of dosage forms.

Our services include crystal form screening and particle design (including composite particles and co-crystals), addressing issues of poor solubility and stability, improved delivery, and product enhancement in support of lifecycle management. Our process is scaled to GMP manufacturing levels. We are also engaged in in-house programmes to develop improved products and currently have licensing opportunities available in several therapeutic areas, including urge incontinence, fungal infections, and malaria.

The first product based on this technology platform is an inhaled product for migraine which has progressed to marketing authorisation application stage – supercritical antisolvent processing enables exceptional particle size control and lung deposition resulting in rapid uptake. Particle design and scale-up to GMP for this product were managed by members of the Crystec team.

Site Badges
Crystec Pharma - Bradford
Crystec Ltd, Norcroft Building Bradford, West Yorkshire, BD7 1DP United Kingdom
Crystec Pharma
Crystec Ltd, Norcroft Building Bradford, West Yorkshire, BD7 1DP United Kingdom

Get started

To request access, simply fill out the form below and we will contact you.

Password must:

• Be at least 12 characters in length

• Contain a lowercase letter (a-z)

• Contain an uppercase letter (A-Z)

• Contain a numeral (0-9)

• Contain a special character (%, $, !, @)

By signing up for this account you agree to the Terms of Service